Stocks to sell

Warner Bros. Discovery (NASDAQ:WBD) has experienced nothing but pain since it completed its merger on April 8. This week has been particularly gruesome for owners of WBD stock. On Tuesday, the company warned about its 2022 profits while also suggesting the integration of WarnerMedia with Discovery Communications wouldn’t go as smoothly as investors would like.

Business travel stocks can’t get enough momentum as travel remains depressed compared to pre-pandemic levels. American Express (AXP): Arguably the company most associated with business travel. Booking Holdings (BKNG): The industry leader when it comes to travel booking websites. Choice Hotels (CHH): Dominant when it comes to mid-level and economy hotel properties in the U.S. Source:

Generac Holdings (NYSE:GNRC), a designer, manufacturer, and seller of power generation equipment, and energy storage systems for home and industrial applications will announce its first quarter 2022 financial results on May 4. Is GNRC stock a buy ahead of earnings? I would say no. The company had a very strong financial performance in fourth quarter

Not surprisingly, AMC Entertainment (NYSE:AMC) stock is on another losing streak. And even if the company’s next earnings report shows some improvement, I’m staying away from this struggling movie theater stock. AMC stock is down more than 45% just in the last month, falling close to $15 per share. That’s still better than where it

After multiple neurology experts harshly criticized Cassava Sciences’ (NASDAQ:SAVA) main thesis and the integrity of its data, I strongly recommend investors refrain from owning any shares of SAVA stock. In my many years of writing about pharmaceutical companies, I’ve never seen multiple experts criticize a drug maker so harshly. These professionals’ tremendous skepticism towards Cassava

Canopy Growth Corporation (NASDAQ:CGC) stock is losing luster on Wall Street due to its inability to deliver profits over the last two years. CGC stock momentarily zoomed on the hope of full legalization of cannabis in the U.S. However, the timing of it being completely legalized remains uncertain. CGC management has high expectations for the

Teladoc (NASDAQ:TDOC) stock slumped by more than 50% after the company’s first-quarter earnings report disappointed. TDOC reported a revenue miss of $3.28 million, caused by an abrupt drawdown in its sales cycle. It seems as though the competitive sphere is heating up in the telehealth space, causing crowdedness in the industry. Teladoc’s return on invested

Ocugen (NASDAQ:OCGN) was one of the most explosive stocks, at one point. In fact, from a December 2020 low of about 29 cents, the stock exploded to $17.65 by November 2021. All thanks to hopes for its coronavirus vaccine, Covaxin. Even Noble Financial analyst Robert LeBoyer had an outperform rating on the stock, with a

Robinhood Markets’ (HOOD) stock has collapsed, falling 74% since last autumn. The company is losing users on its trading app and racking up big losses. While Robinhood has launched several initiatives to improve its situation, HOOD stock continues to fall. Source: dennizn / Shutterstock.com Down 74% in the past six months and 88% below its

Lucid Group (NASDAQ:LCID) is down over 52.4% YTD, which implies that it has to rise by 115.7% just to get even with the end of 2021. That means that investors have truly lost faith in the valuation of LCID stock. The main reason it is still reeling from the disastrous fourth-quarter earnings release on Feb 28. Lucid

Snap (SNAP) earnings disappointed analysts. It now calls itself an “augmented reality company,” eschewing the social media label. Snap is husbanding cash as it waits out the social media firestorm. Investors should do the same. Source: franviser / Shutterstock.com Snap (NASDAQ:SNAP) missed earnings estimates but the stock has been surprisingly resilient. Shares went on a roller

Clover Health (CLOV) stock has continued to weaken in a weak market Its technology looks sound, but it lacks the scale to succeed When fear replaces greed, run away from speculation Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ:CLOV) stock can’t do well in the present stock market environment. Shares are down 22% since the

Snowflake (NYSE:SNOW) has many positive characteristics, including extremely rapid growth, many prominent customers, “great technology,” a CEO who has been extremely successful in the past, and a very promising initiative. Additionally, Snowflake expects its cash flow to be positive this year. However, I don’t expect SNOW stock to perform very well over the next six

Shares of Tilray (NASDAQ:TLRY) continue to slide lower and are down 70% over the last year. The company’s latest earnings showed that its share of the Canadian cannabis market is declining. A new joint venture with fellow Canadian cannabis producer Hexo Corp. (HEXO) raises more questions than it answers. Source: viewimage / Shutterstock.com Canadian cannabis

American Airlines (AAL): Credit metrics have worsened since the pandemic and the airline faces significant debt servicing costs. Renewed slowdown would imply an extended period of cash burn. United Airlines (UAL): Another airline company that has a stretched balance sheet. Focus on recovery will be on deleveraging. Equity dilution remains a possibility. Delta Air Lines

Novavax (NVAX) has dropped to a price that looks cheap if it manages to hit the low end of analyst earnings estimates. However, it’s still trading at a premium to a “worst case scenario” valuation. More disappointment could push it to lower prices. Source: pixinoo / Shutterstock.com The term “falling knife” may be cliché, yet

Salesforce (CRM) — Shares slipped below the 200-weekly moving average and have a long way to go until the next support zone. Alcoa (AA) — Has been hammered after reporting earnings numbers that failed to justify its meteoric rise. Nvidia (NVDA) — The unwind in semiconductors accelerated Thursday, causing NVDA to crack a major floor. Source:

Cable One (CABO): While a strong performer since its debut in 2015, the same can’t be said about its potential performance going forward. Carnival Corporation (CCL): Many challenges signal it’s not time to go “full steam ahead” on this cruise line operator’s shares. Caesars Entertainment (CZR): Be careful about placing a wager that it makes an

Social media company Snap (NYSE:SNAP) reported earnings Thursday afternoon. The numbers were soft across the board. The company missed earnings, missed revenues, and offered up soft guidance for next quarter as well. All in all, it was a bad report, and SNAP stock initially spiked lower on the news. Shares dropped as much as 20% in

Mullen Automotive (MULN) garnered plenty of macabre headlines for short seller’s report that took down MULN stock. In reality, even without the exposé, shares of the EV manufacturer would have likely faced serious trouble. It’s time for investors to start thinking very carefully about the electric transition. Source: Ringo Chiu / Shutterstock.com If you’re following